The present study evaluated Trop2 expression in cervical cancer and showed that almost all cancers were positive for Trop2, regardless of histological tumor type (squamous versus adenocarcinomas) and p16 expression status (Table 3; Figures 3A,B, 4A–C). The gene discussed is TACSTD2; the disease is cervical carcinoma.